Analytical dynamic programming tracker
Visual tracking is formulated as an optimization problem of the position of a target object on
video frames. This paper proposes a new tracking method based on dynamic programming (…
video frames. This paper proposes a new tracking method based on dynamic programming (…
Object Tracking by a Combination of Discrete DP and Analytical DP
(in English) Visual object tracking by popular dynamic programming (DP) requires huge
computations, although it can provide stable tracking results. As a solution of this computational …
computations, although it can provide stable tracking results. As a solution of this computational …
Safety and efficacy of bexarotene for Japanese patients with cutaneous T‐cell lymphoma: Real‐world experience from post‐marketing surveillance
…, A Morita, H Suga, H Boki, T Fujimura… - The Journal of …, 2022 - Wiley Online Library
To establish real‐world evidence about the safety and efficacy of bexarotene for Japanese
patients with cutaneous T‐cell lymphoma, we conducted a nationwide cohort study using …
patients with cutaneous T‐cell lymphoma, we conducted a nationwide cohort study using …
[HTML][HTML] Outcome of combination therapy using BRAF and MEK inhibitors among Asian patients with advanced melanoma: an analysis of 112 cases
…, T Maekawa, J Asai, Y Yamamoto, T Fujimura… - European Journal of …, 2021 - Elsevier
Background As most clinical trials evaluating BRAF and MEK inhibitor combination therapy (B
+ Minh) have been conducted in Western countries, little is known about the effect of B + …
+ Minh) have been conducted in Western countries, little is known about the effect of B + …
Bexarotene-induced hypothyroidism and dyslipidemia; a nation-wide study
…, M Taguchi, A Morita, H Suga, H Boki, T Fujimura… - Endocrine …, 2024 - jstage.jst.go.jp
Central hypothyroidism and dyslipidemia are well-known adverse events (AEs) of bexarotene
therapy. Although hypothyroidism is known to cause dyslipidemia, no study has examined …
therapy. Although hypothyroidism is known to cause dyslipidemia, no study has examined …
[BOOK][B] Computer Vision: Aav 2010
The four-volume set LNCS 6492-6495 constitutes the thoroughly refereed post-proceedings
of the 10th Asian Conference on Computer Vision, ACCV 2009, held in Queenstown, New …
of the 10th Asian Conference on Computer Vision, ACCV 2009, held in Queenstown, New …
Bexarotene-induced hypothyroidism and dyslipidemia; a nation-wide study
…, H Yoji, S Takatoshi, T Chiharu, K Eiji, M Ikko… - Endocrine Journal, 2024 - cir.nii.ac.jp
Central hypothyroidism and dyslipidemia are well-known adverse events (AEs) of bexarotene
therapy. Although hypothyroidism is known to cause dyslipidemia, no study has examined …
therapy. Although hypothyroidism is known to cause dyslipidemia, no study has examined …
NUP160–SLC43A3 is a novel recurrent fusion oncogene in angiosarcoma
N Shimozono, M Jinnin, M Masuzawa, M Masuzawa… - Cancer research, 2015 - AACR
Angiosarcoma is a malignant vascular tumor originating from endothelial cells of blood vessels
or lymphatic vessels. The specific driver mutations in angiosarcoma remain unknown. In …
or lymphatic vessels. The specific driver mutations in angiosarcoma remain unknown. In …
Attenuating effect of angiotensin-(1–7) on angiotensin II-mediated NAD(P)H oxidase activation in type 2 diabetic nephropathy of KK-Ay/Ta mice
JY Moon, M Tanimoto, T Gohda… - American Journal …, 2011 - journals.physiology.org
ANG-(1–7) is associated with vasodilation and nitric oxide synthase stimulation. However,
the role of ANG-(1–7) in type 2 diabetes mellitus is unknown. In this study, we examined the …
the role of ANG-(1–7) in type 2 diabetes mellitus is unknown. In this study, we examined the …
Hypoxia accelerates the progression of angiosarcoma through the regulation of angiosarcoma cells and tumor microenvironment
S Maeda-Otsuka, I Kajihara, Y Tasaki… - Journal of …, 2019 - Elsevier
Background Angiosarcoma is a rare malignant tumor with a poor prognosis. It is known that
hypoxic condition activates tumor progression in several cancers. Additionally, hypoxic tumor …
hypoxic condition activates tumor progression in several cancers. Additionally, hypoxic tumor …